Lunit Cancer Screening

Lunit Cancer Screening is dedicated to conquering cancer through the power of artificial intelligence. As a prominent software development company specializing in medical AI, Lunit Cancer Screening offers cutting-edge solutions designed to enhance diagnostic performance in cancer screening and treatment. Their AI-driven tools for chest X-ray and 2D & 3D mammography have been rigorously validated through numerous publications in prestigious peer-reviewed journals, including JAMA Oncology, Lancet Digital Health, and Radiology. These advanced technologies are currently utilized in over 3,500 sites worldwide.

Lunit Cancer Screening provides the Lunit AI Suite for Radiology, which includes Lunit INSIGHT CXR (AI Solution for Chest X-ray), Lunit INSIGHT MMG (AI Solution for Mammography), Lunit INSIGHT DBT (AI Solution for Digital Breast Tomosynthesis), and Lunit CXR Triage (AI solution for Chest X-ray Triage, available in the US only for emergency department use). With a primary address in Boston, Massachusetts, US, and another location in Amsterdam, NL, Lunit Cancer Screening is strategically positioned to serve a global clientele. The company’s commitment to innovation and excellence makes it a key player in the advancement of medical imaging and cancer detection.

Lunit Cancer Screening continues to push the boundaries of what’s possible in medical AI, striving to improve patient outcomes and support healthcare professionals with state-of-the-art technology. Explore the potential of Lunit Cancer Screening to transform cancer diagnostics and treatment. We invite the manager of Lunit Cancer Screening to create a customized and exclusive company showcase and product listing on our platform, further highlighting your contributions to the field.